HESTERBIO Share Price Target 2030

CAGR-based price projection for Hester Biosciences Limited (HESTERBIO) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (18.5% CAGR)
Rs 4,192
2030 Target
Base Case (46.2% CAGR)
Rs 9,720
2030 Target
Bull Case (147.9% CAGR)
Rs 80,339
2030 Target

Current Market Snapshot

CMP: Rs 2,126.80
52W High: Rs 2,545.00
52W Low: Rs 1,447.80
1Y CAGR: 113.8%
3Y CAGR: 46.2%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 2,520 Rs 3,110 Rs 5,273
2028 Rs 2,986 Rs 4,547 Rs 13,072
2029 Rs 3,538 Rs 6,648 Rs 32,406
2030 Rs 4,192 Rs 9,720 Rs 80,339

Other HESTERBIO Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the HESTERBIO share price target for 2030?

Based on historical growth analysis, the HESTERBIO share price target for 2030 ranges from Rs 4,192 (conservative) to Rs 9,720 (base case) to Rs 80,339 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of HESTERBIO?

The current market price of HESTERBIO (Hester Biosciences Limited) is Rs 2,126.80. The 52-week high is Rs 2,545.00 and 52-week low is Rs 1,447.80.

Is HESTERBIO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for HESTERBIO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 18.5% CAGR), Base (46.2% CAGR), and Bull (optimistic at 147.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.